# NUC-1031 in Patients With Advanced Solid Tumours

> **NCT01621854** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 68 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** NUC-1031

## Key facts

- **NCT ID:** NCT01621854
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621854, "NUC-1031 in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT01621854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*